These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9455974

  • 1. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits.
    Perez-Pinzon MA, Yenari MA, Sun GH, Kunis DM, Steinberg GK.
    J Neurol Sci; 1997 Dec 09; 153(1):25-31. PubMed ID: 9455974
    [Abstract] [Full Text] [Related]

  • 2. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia.
    Takizawa S, Matsushima K, Fujita H, Nanri K, Ogawa S, Shinohara Y.
    J Cereb Blood Flow Metab; 1995 Jul 09; 15(4):611-8. PubMed ID: 7790409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.
    Yenari MA, Palmer JT, Sun GH, de Crespigny A, Mosely ME, Steinberg GK.
    Brain Res; 1996 Nov 11; 739(1-2):36-45. PubMed ID: 8955922
    [Abstract] [Full Text] [Related]

  • 5. Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats.
    Bowersox SS, Singh T, Luther RR.
    Brain Res; 1997 Feb 07; 747(2):343-7. PubMed ID: 9046013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK, Lo EH, Kunis DM, Grant GA, Poljak A, DeLaPaz R.
    Neurosci Lett; 1991 Dec 09; 133(2):225-8. PubMed ID: 1816501
    [Abstract] [Full Text] [Related]

  • 8. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures.
    Pringle AK, Benham CD, Sim L, Kennedy J, Iannotti F, Sundstrom LE.
    Stroke; 1996 Nov 09; 27(11):2124-30. PubMed ID: 8898826
    [Abstract] [Full Text] [Related]

  • 9. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.
    Pérez-Pinzón MA, Maier CM, Yoon EJ, Sun GH, Giffard RG, Steinberg GK.
    J Cereb Blood Flow Metab; 1995 Sep 09; 15(5):865-76. PubMed ID: 7673380
    [Abstract] [Full Text] [Related]

  • 10. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia.
    Valentino K, Newcomb R, Gadbois T, Singh T, Bowersox S, Bitner S, Justice A, Yamashiro D, Hoffman BB, Ciaranello R.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7894-7. PubMed ID: 8102803
    [Abstract] [Full Text] [Related]

  • 11. Autoradiographic localization of N-type VGCCs in gerbil hippocampus and failure of omega-conotoxin MVIIA to attenuate neuronal injury after transient cerebral ischemia.
    Azimi-Zonooz A, Kawa CB, Dowell CD, Olivera BM.
    Brain Res; 2001 Jul 13; 907(1-2):61-70. PubMed ID: 11430886
    [Abstract] [Full Text] [Related]

  • 12. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    Bowersox SS, Miljanich GP, Sugiura Y, Li C, Nadasdi L, Hoffman BB, Ramachandran J, Ko CP.
    J Pharmacol Exp Ther; 1995 Apr 13; 273(1):248-56. PubMed ID: 7714772
    [Abstract] [Full Text] [Related]

  • 13. Ziconotide. CI 1009, SNX 111.
    Drugs R D; 1999 Jan 13; 1(1):46-8. PubMed ID: 10565986
    [No Abstract] [Full Text] [Related]

  • 14. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM.
    Brain Res; 2001 Aug 03; 909(1-2):46-50. PubMed ID: 11478919
    [Abstract] [Full Text] [Related]

  • 15. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats.
    Colbourne F, Li H, Buchan AM, Clemens JA.
    Stroke; 1999 Mar 03; 30(3):662-8. PubMed ID: 10066868
    [Abstract] [Full Text] [Related]

  • 16. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111).
    Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP.
    Neurol Res; 1997 Jun 03; 19(3):334-9. PubMed ID: 9192388
    [Abstract] [Full Text] [Related]

  • 17. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK, George CP, DeLaPaz R, Shibata DK, Gross T.
    Stroke; 1988 Sep 03; 19(9):1112-8. PubMed ID: 3413809
    [Abstract] [Full Text] [Related]

  • 18. A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat.
    Tanaka K, Ito D, Suzuki S, Dembo T, Kosakai A, Fukuuchi Y.
    Brain Res; 2002 Jan 04; 924(1):98-108. PubMed ID: 11744000
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transient brain ischemia in rabbits: the effect of omega-conopeptide MVIIC on hippocampal excitatory amino acids.
    Wu G, Kim HK, Zornow MH.
    Brain Res; 1995 Sep 18; 692(1-2):118-22. PubMed ID: 8548294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.